The global local anesthesia drugs market accounted for a market value of
USD 8,160 million in 2015 and is expected to reach USD 8,335 million in
2016. The market is expected to reach USD 9,240 million by 2021, growing
at a CAGR of 2.1% during the forecast period of 2016 to 2021.

Local anesthetics functions by blocking the generation and the
conduction of nerve impulses. The blocking is mostly done by increasing
the threshold for electrical excitation in the nerve, by slowing the
propagation of the nerve impulse and by reducing the rate of rise of the
action potential. The effect and progression of anaesthesia is mostly
related to the diameter, myelination and conduction velocity of affected
nerve fibres. The order by which the nerve loses its functionality will
be as follows: pain, temperature, touch, proprioception and skeletal
muscle tone.

The common drugs in local anaesthetics can be chemically classified as:
a) Ester linked Local Anesthetics like Cocaine, Procaine,
Chloroprocaine, Tetracaine, benzocaine and others. b) Amide linked Local
anesthetics such as Lidocaine, Bupivacaine, dibucaine, prilocaine,
ropivacaine and others.

Increase incidences of surgeries, trends in cosmetic surgery procedures,
increasing dental procedures, plastic surgery and lesser side effects
compared to general anaesthetics are the primary drivers that is
propelling the growth of the market.

In this report the global local anesthesia drugs market have been
segmented based on drugs, applications, and geography.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her
physician.